Zijian Guo

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Engineered polypeptides having enhanced duration of action
- Patent number 11,535,659
- Issue date Dec 27, 2022
- Amryt Pharmaceuticals Inc.
- Mary Erickson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineered polypeptides having enhanced duration of action and redu...
- Patent number 9,879,063
- Issue date Jan 30, 2018
- Aegerion Pharmaceuticals, Inc.
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered polypeptides having enhanced duration of action
- Patent number 9,593,154
- Issue date Mar 14, 2017
- Astrazeneca Pharmaceuticals LP
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered polypeptides having enhanced duration of action with red...
- Patent number 9,382,304
- Issue date Jul 5, 2016
- Amylin Pharmaceuticals, LLC
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cloning and functional assays of Xenopus ATR
- Patent number 7,098,007
- Issue date Aug 29, 2006
- California Institute of Technology
- William Dunphy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Checkpoint-activating oligonucleotides
- Patent number 6,593,110
- Issue date Jul 15, 2003
- California Institute of Technology
- Zijian Guo
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING

Patents Applicationslast 30 patents

Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
- Publication number 20230115655
- Publication date Apr 13, 2023
- Amryt Pharmaceuticals Inc.
- Mary ERICKSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
- Publication number 20200362006
- Publication date Nov 19, 2020
- Aegerion Pharmaceuticals, Inc.
- Mary Erickson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH RED...
- Publication number 20180344813
- Publication date Dec 6, 2018
- AMYLIN PHARMACEUTICALS, LLC
- Mary ERICKSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Engineered Polypeptides Having Enhanced Duration of Action and Redu...
- Publication number 20180305430
- Publication date Oct 25, 2018
- Aegerion Pharmaceuticals, Inc.
- Mary Erickson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
- Publication number 20170114114
- Publication date Apr 27, 2017
- Amylin Pharmaceuticals, LLC
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDU...
- Publication number 20160207974
- Publication date Jul 21, 2016
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
- Publication number 20160137709
- Publication date May 19, 2016
- Aegerion Pharmaceuticals, Inc.
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED POYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUC...
- Publication number 20140256621
- Publication date Sep 11, 2014
- ASTRAZENECA PHARMACEUTICALS LP
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH RED...
- Publication number 20140235535
- Publication date Aug 21, 2014
- ASTRAZENECA PHARMACEUTICALS LP
- Mary Erickson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
- Publication number 20140107019
- Publication date Apr 17, 2014
- Astrazeneca Pharmaceuticals LP
- Mary ERICKSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
- Publication number 20130274182
- Publication date Oct 17, 2013
- Mary Erickson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for increasing drug efficiency
- Publication number 20060234909
- Publication date Oct 19, 2006
- Michael James Newman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for increasing drug efficiency
- Publication number 20050187147
- Publication date Aug 25, 2005
- Michael James Newman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Checkpoint-activating oligonucleotides
- Publication number 20040018603
- Publication date Jan 29, 2004
- Zijian Guo
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Cloning and functional assays of Xenopus ATR
- Publication number 20030108916
- Publication date Jun 12, 2003
- William Dunphy
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Checkpoint-activating oligonucleotides
- Publication number 20020086392
- Publication date Jul 4, 2002
- Zijian Guo
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Engineered polypeptides having enhanced duration of action

Engineered polypeptides having enhanced duration of action and redu...

Engineered polypeptides having enhanced duration of action

Engineered polypeptides having enhanced duration of action with red...

Cloning and functional assays of Xenopus ATR

Checkpoint-activating oligonucleotides

Patents Applicationslast 30 patents

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH RED...

Engineered Polypeptides Having Enhanced Duration of Action and Redu...

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDU...

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION

ENGINEERED POYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUC...

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH RED...

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION

Compositions and methods for increasing drug efficiency

Compositions and methods for increasing drug efficiency

Checkpoint-activating oligonucleotides

Cloning and functional assays of Xenopus ATR

Checkpoint-activating oligonucleotides